持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/01/28 | 4,175 | 4,225 | 4,145 | 4,200 | -20 | -0.5% | 56,200 |
2020/01/27 | 4,250 | 4,250 | 4,205 | 4,220 | -100 | -2.3% | 39,900 |
2020/01/24 | 4,355 | 4,355 | 4,315 | 4,320 | -35 | -0.8% | 37,300 |
2020/01/23 | 4,390 | 4,390 | 4,320 | 4,355 | -65 | -1.5% | 47,000 |
2020/01/22 | 4,445 | 4,450 | 4,395 | 4,420 | +5 | +0.1% | 38,200 |
2020/01/21 | 4,395 | 4,430 | 4,395 | 4,415 | -25 | -0.6% | 30,600 |
2020/01/20 | 4,400 | 4,445 | 4,400 | 4,440 | +25 | +0.6% | 21,400 |
2020/01/17 | 4,400 | 4,435 | 4,380 | 4,415 | +50 | +1.1% | 42,100 |
2020/01/16 | 4,370 | 4,390 | 4,320 | 4,365 | ±0 | ±0% | 48,600 |
2020/01/15 | 4,410 | 4,430 | 4,345 | 4,365 | -10 | -0.2% | 42,900 |
2020/01/14 | 4,400 | 4,400 | 4,310 | 4,375 | -70 | -1.6% | 68,100 |
2020/01/10 | 4,435 | 4,480 | 4,425 | 4,445 | +40 | +0.9% | 35,300 |
2020/01/09 | 4,415 | 4,435 | 4,335 | 4,405 | +55 | +1.3% | 33,000 |
2020/01/08 | 4,315 | 4,395 | 4,275 | 4,350 | -35 | -0.8% | 56,500 |
2020/01/07 | 4,290 | 4,405 | 4,290 | 4,385 | +100 | +2.3% | 39,800 |
2020/01/06 | 4,360 | 4,360 | 4,275 | 4,285 | -125 | -2.8% | 55,000 |
2019/12/30 | 4,445 | 4,460 | 4,405 | 4,410 | -70 | -1.6% | 34,700 |
2019/12/27 | 4,435 | 4,515 | 4,415 | 4,480 | +45 | +1% | 30,800 |
2019/12/26 | 4,445 | 4,450 | 4,405 | 4,435 | +5 | +0.1% | 43,600 |
2019/12/25 | 4,475 | 4,475 | 4,410 | 4,430 | -65 | -1.4% | 23,600 |
2019/12/24 | 4,570 | 4,570 | 4,465 | 4,495 | -80 | -1.7% | 40,500 |
2019/12/23 | 4,595 | 4,595 | 4,565 | 4,575 | -25 | -0.5% | 20,800 |
2019/12/20 | 4,635 | 4,645 | 4,540 | 4,600 | +20 | +0.4% | 53,700 |
2019/12/19 | 4,585 | 4,610 | 4,535 | 4,580 | -10 | -0.2% | 50,500 |
2019/12/18 | 4,640 | 4,645 | 4,570 | 4,590 | -40 | -0.9% | 61,100 |
2019/12/17 | 4,560 | 4,630 | 4,530 | 4,630 | +120 | +2.7% | 52,000 |
2019/12/16 | 4,560 | 4,580 | 4,510 | 4,510 | -45 | -1% | 46,800 |
2019/12/13 | 4,570 | 4,625 | 4,550 | 4,555 | +50 | +1.1% | 102,600 |
2019/12/12 | 4,535 | 4,545 | 4,505 | 4,505 | -30 | -0.7% | 43,600 |
2019/12/11 | 4,550 | 4,565 | 4,520 | 4,535 | -15 | -0.3% | 50,600 |
2019/12/10 | 4,530 | 4,580 | 4,520 | 4,550 | +40 | +0.9% | 61,000 |
2019/12/09 | 4,505 | 4,520 | 4,430 | 4,510 | +35 | +0.8% | 34,800 |
2019/12/06 | 4,540 | 4,540 | 4,445 | 4,475 | -40 | -0.9% | 51,800 |
2019/12/05 | 4,510 | 4,540 | 4,500 | 4,515 | +25 | +0.6% | 55,200 |
2019/12/04 | 4,450 | 4,495 | 4,430 | 4,490 | +30 | +0.7% | 48,100 |
2019/12/03 | 4,485 | 4,495 | 4,435 | 4,460 | -15 | -0.3% | 55,900 |
2019/12/02 | 4,445 | 4,485 | 4,440 | 4,475 | +75 | +1.7% | 39,700 |
2019/11/29 | 4,455 | 4,460 | 4,400 | 4,400 | -30 | -0.7% | 42,900 |
2019/11/28 | 4,450 | 4,450 | 4,400 | 4,430 | -30 | -0.7% | 45,200 |
2019/11/27 | 4,460 | 4,500 | 4,460 | 4,460 | +15 | +0.3% | 46,000 |
2019/11/26 | 4,480 | 4,480 | 4,440 | 4,445 | +5 | +0.1% | 50,000 |
2019/11/25 | 4,465 | 4,480 | 4,410 | 4,440 | +15 | +0.3% | 30,200 |
2019/11/22 | 4,425 | 4,465 | 4,380 | 4,425 | ±0 | ±0% | 56,900 |
2019/11/21 | 4,440 | 4,470 | 4,350 | 4,425 | -35 | -0.8% | 43,400 |
2019/11/20 | 4,430 | 4,465 | 4,400 | 4,460 | +40 | +0.9% | 55,400 |
2019/11/19 | 4,380 | 4,430 | 4,375 | 4,420 | +40 | +0.9% | 45,200 |
2019/11/18 | 4,350 | 4,385 | 4,345 | 4,380 | +15 | +0.3% | 51,300 |
2019/11/15 | 4,325 | 4,380 | 4,325 | 4,365 | +65 | +1.5% | 55,400 |
2019/11/14 | 4,345 | 4,345 | 4,290 | 4,300 | -30 | -0.7% | 46,200 |
2019/11/13 | 4,390 | 4,395 | 4,330 | 4,330 | -45 | -1% | 54,700 |
1301~
1350
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 297,700円 | +5.1% | -7.0% | 2.69% | 19.55倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 212,700円 | +3.1% | -6.5% | 2.26% | 9.87倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 145,700円 | -2.4% | -52.3% | 3.91% | 17.43倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 201,800円 | +4.1% | -3.1% | 2.87% | 17.70倍 | 1.54倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム